Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)

Rheumatology (United Kingdom)

Volumn 53, Issue 2, 2014, Pages 321-331

  Ramos Casals, Manuel ^a   Brito Zerón, Pilar ^a   Solans, Roser ^b   Camps, María Teresa ^c   Casanovas, Arnau ^d   Sopeña, Bernardo ^e   Díaz López, Bernardino ^f   Rascón, Francisco Javier ^g   Qanneta, Rami ^h   Fraile, Guadalupe ⁱ   Pérez Alvarez, Roberto ^j   Callejas, José Luis ^k   Ripoll, Mar ^l   Pinilla, Blanca ^m   Akasbi, Miriam ⁿ   Fonseca, Eva ^o   Canora, Jesús ^p   Nadal, María Elvira ^q   de la Red, Gloria ^r   Fernández Regal, Inés ^e   Jiménez Heredia, Iratxe ^s   Bosch, Josep Angel ^b   Ayala, María del Mar ^c   Morera Morales, Lluisa ^d   Maure, Brenda ^e   Mera, Arantxa ^f   Ramentol, Marc ^b   Retamozo, Soledad ^a   Kostov, Belchin ^t   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e Complejo Hospitalario Universitario ^*  (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j HOSPITAL DO MEIXOEIRO   (Spain)

^k HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^l HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁿ HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^o HOSPITAL DE CABUEÑES   (Spain)

^p HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^q Hospital La Ribera   (Spain)

^r Hospital Espíritu Santo   (Spain)

^s HOSPITAL DE MANISES   (Spain)

^t INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

more..

Author keywords

Anti Ro SS A antibodies; Cryoglobulins; Extraglandular involvement; Hypocomplementemia; Primary Sj gren's syndrome

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RHEUMATOID FACTOR; RITUXIMAB; RO ANTIBODY;

ADULT; ANEMIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; CRYOGLOBULINEMIA; CYTOPENIA; DISEASE ACTIVITY; DRY EYE; EULAR SS DISEASE ACTIVITY INDEX; FEMALE; FOLLOW UP; HUMAN; HYPOCOMPLEMENTEMIA; KIDNEY; LEUKOPENIA; LUNG; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR SYSTEM; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; SKIN; THROMBOCYTOPENIA; XEROSTOMIA;

ANTI-RO/SS-A ANTIBODIES; CRYOGLOBULINS; EXTRAGLANDULAR INVOLVEMENT; HYPOCOMPLEMENTEMIA; PRIMARY SJÖGREN'S SYNDROME;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINT DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; REGISTRIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SKIN DISEASES; SPAIN;

EID: 84892496831     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket349     Document Type: Article

References (41)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A et al. Primary Sjogren syndrome. BMJ 2012;344:e3821.
2. Birlik M, Akar S, Gurler O et al. Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract 2009;63:954-61.
3. Anagnostopoulos I, Zinzaras E, Alexiou I et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010;11:98.
4. Gøransson LG, Haldorsen K, Brun JG et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011;40:221-4.
5. Brito-Zerón P, Ramos-Casals M, Bove A et al. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology 2007;46:1359-62.
6. Jonsson R, Bolstad AI, Brokstad KA et al. Sjögren's syndrome-a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007;1108:433-47.
7. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275-84.
8. Goules AV, Skopouli FN. Prognostic factors and survival. In: Ramos-Casals M, Stone JH, Moutsopoulos HM, eds. Sjögren syndrome: diagnosis and therapeutics. London: Springer, 2012:129-48.
9. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-54.
10. Ioannidis J, Vassiliou V, Moutsopoulos H. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
11. Theander E, Manthorpe R, Jacobsson L. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50: 1262-9.
12. Ramos-Casals M, Solans R, Rosas J et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008;87:210-9.
13. Friedman JA, Miller EB, Green L et al. A community-based cohort of 201 consecutive patients with primary Sjögren's syndrome in Israel: Ashkenazi patients compared with those of Sephardic descent. Clin Exp Rheumatol 2006;24: 274-80.
14. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69: 1103-9.
15. Seror R, Bootsma H, Bowman SJ et al. Outcome measures for primary Sjögren's syndrome. J Autoimmun 2012;39:97-102.
16. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
17. Online GEAS-SEMI clinical guidelines for the diagnostic, therapeutic and follow-up management of patients with primary Sjögren syndrome. http://www.fesemi.org/ grupos/autoinmunes/docencia/guias/view (4 April 2013, date last accessed).
18. Risselada AP, Kruize AA, Bijlsma JW. Clinical applicability of the EULAR Sjogren's syndrome disease activity index: a cumulative ESSDAI score adds in describing disease severity. Ann Rheum Dis 2012;71:631.
19. Ramos-Casals M, Daniels TE, Fox RI et al. Sjögren syndrome. In: Stone JH, ed. A clinician's pearls and myths in rheumatology. London: Springer, 2009:107-30.
20. Haga H, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome. Scand J Rheumatol 1999;28: 227-232.
21. Ramos-Casals M, Cervera R, Font J et al. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Lupus 1998;7:202-6.
22. Soto-Cardenas MJ, Perez-De-Lis M, Bove A et al. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance. Clin Exp Rheumatol 2010;28: 647-53.
23. Yazisiz V, Arslan G, Ozbudak IH et al. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors? Rheumatol Int 2010;30:1317-24.
24. Theander E, Vasaitis L, Baecklund E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011;70: 1363-8.
25. Ramos-Casals M, Font J, Garcia-Carrasco M et al. Primary Sjögren syndrome: hematologic patterns of disease expression. Medicine 2002;81:281-92.
26. Baimpa E, Dahabreh IJ, Voulgarelis M et al. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine 2009;88:284-93.
27. Alexander E, Arnett F, Provost T et al. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983;98:155-9.
28. Retamozo S, Akasbi M, Brito-Zeron P et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome. Clin Exp Rheumatol 2012;30:686-92.
29. Vanarsa K, Ye Y, Han J et al. Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther 2012;14:R182.
30. Ramos-Casals M, Nardi N, Lagrutta M et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine 2006;85:95-104.
31. Brito-Zerón P, Soria N, Muñoz S et al. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome. Semin Arthritis Rheum 2009;38:389-95.
32. Theander E, Henriksson G, Ljungberg O et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
33. Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology 2000;39:1316-9.
34. Gladman DD. Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1994;6:487-92.
35. Peen E, Mellbye OJ, Haga HJ. IgA rheumatoid factor in primary Sjogren's syndrome. Scand J Rheumatol 2009;38: 46-9.
36. ter Borg EJ, Risselada AP, Kelder JC. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 2011;40:547-51.
37. Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun 2012;39:15-26.
38. Malladi AS, Sack KE, Shiboski SC et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res 2012;64:911-8.
39. Pertovaara M, Korpela M. Serum b2 microglobulin correlates with the new ESSDAI in patients with Sjögren's syndrome. Ann Rheum Dis 2011;70:2236-7.
40. Meiners PM, Arends S, Brouwer E et al. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. Ann Rheum Dis 2012;71:1297-302.
41. Seror R, Theander E, Brun JG et al. Validation of EULAR primary Sjögren's syndrome disease activity and patient indexes. Arthritis Rheum (Suppl) 2013 (abstract ACR, in press).